These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26216942)

  • 1. MRP4 Modulation of the Guanylate Cyclase-C/cGMP Pathway: Effects on Linaclotide-Induced Electrolyte Secretion and cGMP Efflux.
    Tchernychev B; Ge P; Kessler MM; Solinga RM; Wachtel D; Tobin JV; Thomas SR; Lunte CE; Fretzen A; Hannig G; Bryant AP; Kurtz CB; Currie MG; Silos-Santiago I
    J Pharmacol Exp Ther; 2015 Oct; 355(1):48-56. PubMed ID: 26216942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine.
    Ahsan MK; Tchernychev B; Kessler MM; Solinga RM; Arthur D; Linde CI; Silos-Santiago I; Hannig G; Ameen NA
    Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28592587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.
    Busby RW; Bryant AP; Bartolini WP; Cordero EA; Hannig G; Kessler MM; Mahajan-Miklos S; Pierce CM; Solinga RM; Sun LJ; Tobin JV; Kurtz CB; Currie MG
    Eur J Pharmacol; 2010 Dec; 649(1-3):328-35. PubMed ID: 20863829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
    Silos-Santiago I; Hannig G; Eutamene H; Ustinova EE; Bernier SG; Ge P; Graul C; Jacobson S; Jin H; Liong E; Kessler MM; Reza T; Rivers S; Shea C; Tchernychev B; Bryant AP; Kurtz CB; Bueno L; Pezzone MA; Currie MG
    Pain; 2013 Sep; 154(9):1820-1830. PubMed ID: 23748116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
    Castro J; Harrington AM; Hughes PA; Martin CM; Ge P; Shea CM; Jin H; Jacobson S; Hannig G; Mann E; Cohen MB; MacDougall JE; Lavins BJ; Kurtz CB; Silos-Santiago I; Johnston JM; Currie MG; Blackshaw LA; Brierley SM
    Gastroenterology; 2013 Dec; 145(6):1334-46.e1-11. PubMed ID: 23958540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRP4-mediated regulation of intracellular cAMP and cGMP levels in trabecular meshwork cells and homeostasis of intraocular pressure.
    Pattabiraman PP; Pecen PE; Rao PV
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1636-49. PubMed ID: 23385799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract.
    Bryant AP; Busby RW; Bartolini WP; Cordero EA; Hannig G; Kessler MM; Pierce CM; Solinga RM; Tobin JV; Mahajan-Miklos S; Cohen MB; Kurtz CB; Currie MG
    Life Sci; 2010 May; 86(19-20):760-5. PubMed ID: 20307554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linaclotide-a novel secretagogue in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
    Sharma S; Sharma T; Dhingra R; Tomar P; Singh S; Malhotra M; Bhardwaj TR
    Mini Rev Med Chem; 2013 Oct; 13(11):1685-90. PubMed ID: 24001336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylin in the human pancreas: a novel luminocrine regulatory pathway of electrolyte secretion via cGMP and CFTR in the ductal system.
    Kulaksiz H; Schmid A; Hönscheid M; Eissele R; Klempnauer J; Cetin Y
    Histochem Cell Biol; 2001 Feb; 115(2):131-45. PubMed ID: 11444148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated, side-directed secretion of proguanylin from isolated rat colonic mucosa.
    Martin S; Adermann K; Forssmann WG; Kuhn M
    Endocrinology; 1999 Nov; 140(11):5022-9. PubMed ID: 10537127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil versus linaclotide in gastrointestinal dysfunction and depressive behavior in constipation-predominant irritable bowel syndrome.
    Sedky AA; Magdy Y
    Life Sci; 2020 Sep; 256():117960. PubMed ID: 32534033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multidrug resistance protein 4 is expressed and functionally active in isolated bladder from pig.
    Gomes ET; Passos GR; Antunes NJ; de Oliveira MG; de Souza VB; Schenka AA; da Costa JL; Antunes E; Mónica FZ
    Am J Physiol Regul Integr Comp Physiol; 2024 Sep; 327(3):R291-R303. PubMed ID: 38881411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of Angeli's salt, a nitroxyl (HNO) donor, on ion transport across mucosa-submucosa preparations from rat distal colon.
    Pouokam E; Bell A; Diener M
    Eur J Pharmacol; 2013 Sep; 715(1-3):133-41. PubMed ID: 23747594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C.
    Sindić A; Velic A; Başoglu C; Hirsch JR; Edemir B; Kuhn M; Schlatter E
    Kidney Int; 2005 Sep; 68(3):1008-17. PubMed ID: 16105031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil normalizes bowel transit in preclinical models of constipation.
    Sharman SK; Islam BN; Hou Y; Usry M; Bridges A; Singh N; Sridhar S; Rao S; Browning DD
    PLoS One; 2017; 12(4):e0176673. PubMed ID: 28448580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanylin stimulation of Cl- secretion in human intestinal T84 cells via cyclic guanosine monophosphate.
    Forte LR; Eber SL; Turner JT; Freeman RH; Fok KF; Currie MG
    J Clin Invest; 1993 Jun; 91(6):2423-8. PubMed ID: 8390480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins.
    Pattison AM; Blomain ES; Merlino DJ; Wang F; Crissey MA; Kraft CL; Rappaport JA; Snook AE; Lynch JP; Waldman SA
    Infect Immun; 2016 Oct; 84(10):3083-91. PubMed ID: 27481254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
    Busby RW; Kessler MM; Bartolini WP; Bryant AP; Hannig G; Higgins CS; Solinga RM; Tobin JV; Wakefield JD; Kurtz CB; Currie MG
    J Pharmacol Exp Ther; 2013 Jan; 344(1):196-206. PubMed ID: 23090647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of soluble guanylyl cyclase with inhibition of multidrug resistance protein inhibitor-4 (MRP4) as a new antiplatelet therapy.
    Mendes-Silverio CB; Lescano CH; Zaminelli T; Sollon C; Anhê GF; Antunes E; Mónica FZ
    Biochem Pharmacol; 2018 Jun; 152():165-173. PubMed ID: 29605625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport.
    Borgognone A; Pulcinelli FM
    Thromb Haemost; 2012 Nov; 108(5):955-62. PubMed ID: 23014861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.